10Indexed trials
drug · Product Intelligence
Sertraline
Pipeline Intelligence
Sertraline: 10 indexed trials, 10 sponsors; 0 linked Orange Book patents and 8 FDA-linked events where matched.
10Sponsors
0Orange Book patent links
8FDA-linked events
Development evidence
NCT00302068Duke University · depressionPHASE3
NCT00594269Sykehuset Innlandet HF · depressionPHASE4
NCT00693849BRC Operations Pty. Ltd. · depressionPHASE4
NCT00835627Rhode Island Hospital · epilepsyPHASE4
NCT00946998VA Office of Research and Development · depressionPHASE3
NCT01305889University of California, San Francisco · depressionNA
NCT01309074Rush University Medical Center · epilepsyPHASE4
NCT01454635Showa University · depressionNA
NCT01896934Vanderbilt University · depressionPHASE4
NCT02235064The Cooper Health System · depressionNA
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2026-01-20
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2021-05-03
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2010-07-21
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2009-08-10
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2007-02-06
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2007-02-06
FDA_APPROVALSERTRALINE HYDROCHLORIDE · 2007-02-06
FDA_APPROVALZOLOFT · 1999-12-07
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.